Influence of pregnancy on asthma exacerbation patterns: a UK population-based cohort

Valencia-Hernandez,C.,Wong,E.,Bloom,C.

DOI: https://doi.org/10.1183/13993003.congress-2024.oa5577

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:Background: GINA notes that during pregnancy, about one-third of women have worsening asthma symptoms, one-third improve, and one-third remain unchanged. This data is from a US cohort of 330 women from the 1980s. We wished to understand current exacerbation patterns. Methods: Using UK medical records, 2004-2019, we drew an asthma cohort with data: 1-year pre-pregnancy, during all 3 pregnancy trimesters, and 1-year post-pregnancy. We defined exacerbations as a short course of oral steroids or unplanned hospital visit. We calculated the proportion having ≥1 exacerbation in each 3-month period. Results: We included 72,791 pregnancies (mean age=31 years; mean pregnancy length=39 weeks). By asthma therapy in the year pre-pregnancy, 50% only used a reliever, 19% low-dose inhaled corticosteroids (ICS), 16% infrequent medium/high-dose ICS, 11% regular medium-dose ICS and 5% regular high-dose ICS. Overall, hospital-managed exacerbations rose in the second and third trimester. But primary care-managed exacerbations fell in all three trimesters (figure). All exacerbations were lower 3-months post-pregnancy. Conclusion: During pregnancy, there were relatively fewer primary care-managed exacerbations, especially if using higher doses of ICS, but more hospital and A&E admissions. All exacerbations fell 3-months post-pregnancy. By 12-months post-pregnancy, women using the highest ICS doses still had lower exacerbation rates than pre-pregnancy.

respiratory system